AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Gross Profit
AngioDynamics Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AngioDynamics Inc
NASDAQ:ANGO
|
Gross Profit
$162.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is AngioDynamics Inc's Gross Profit?
Gross Profit
162.5m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's Gross Profit amounts to 162.5m USD.
What is AngioDynamics Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
-1%
Over the last year, the Gross Profit growth was -7%. The average annual Gross Profit growth rates for AngioDynamics Inc have been 4% over the past three years , 5% over the past five years , and -1% over the past ten years .